RTTNews | Apr 12, 2021 06:09AM EDT

06:09 Monday, April 12, 2021 (RTTNews) - Cardiff Oncology: Onvansertib Phase 1b/2 Data Continues To Demonstrate Robust Response In KRAS-Mutated MCRC

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved